Moneycontrol PRO
HomeNewsTrendsCurrent AffairsPrivate Hospitals Procured Just 10% of Vaccines Over Last 3 Months against a Quota of 25%

Private Hospitals Procured Just 10% of Vaccines Over Last 3 Months against a Quota of 25%

Private hospitals in Bihar procured not even a single dose in the last three months while only 11 lakh doses were procured by private hospitals in Uttar Pradesh, as per the data furnished in Parliament

August 06, 2021 / 13:56 IST

Private Hospitals procured just 3.5 crore vaccine doses over the last three months against nearly 30 crore doses procured by the central and state governments between May and July, prompting the Centre to now do away with the stipulated 25% quota for the private sector in vaccines.

The latest figures presented before the Parliament on Friday showed that the procurement by private hospitals was only about 10% of the total vaccine stocks against the 25% quota allowed to them.

While the Central government and states procured 29.6 crore doses over the last three months, including stocks directly procured by states during the period when the same was allowed, private hospitals procured only 3.56 crore doses in this period.

Private hospitals in Bihar procured not even a single dose in the last three months while only 11 lakh doses were procured by private hospitals in Uttar Pradesh, as per the data furnished in Parliament. Private hospitals in Maharashtra did procure 1.04 crore vaccines since May.

This has prompted the latest change whereby Health Minister Mansukh Mandaviya told the Parliament earlier this week that vaccine manufacturers had been told to not reserve 25% of the vaccine quota for private hospitals and only supply them as much as they buy.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

The rest of the stock, the government has said, can be supplied to the government at the cost at which the government is buying 75% of the vaccine stock.

“The COVID-19 vaccines once procured by private hospitals is not re-allocated to Government vaccination centres,” the government has clarified to the Parliament.

Focus on the Second Dose

The government has also told Parliament that it is focussing on the second dose as well as and states States/UTs have been advised to prioritize the vaccination for those whose 2nd dose is due.

“States have been advised that completion of both doses is significant from the point of view of not only pandemic management but also to afford full protection to the beneficiaries,” the Health Minister told Parliament. He listed out measures suggested to states for increasing the coverage of the second dose of the vaccine.

“Utilize the advance visibility or information of vaccine supplies for efficient planning of prioritizing the second dose coverage, undertake a regular review of beneficiaries due for 2nd dose and direct the concerned officials to focus on timely completion of their vaccine schedule, enmark certain percentage of monthly vaccine allocation for the 2nd dose or earmark certain days or specified time period during the day for the 2nd dose administration at each COVID-19 vaccination center,” say the specified measures.

The Centre has also suggested to states to establish separate queues for 1st and 2nd dose beneficiaries at the COVID-19 Vaccination centers and mounting a special Information campaign to sensitize beneficiaries about the need and significance of getting the 2nd dose, “thus increasing the acceptance and demand for the same.”

Aman Sharma is a writer at News18
first published: Aug 6, 2021 01:56 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347